Skip to content

SELLAS Life Sciences Group, Inc.

SLS· NasdaqCore metricsCIK 1390478

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -4.58%
Market cap
$1.64B
203.86M shares
Filings
1,010
$0.00
Q3 2026−100.0% FY23 yoy
-$10.09M
Q3 2026N/M FY25 yoy
-$11.31M
Q3 2026N/M FY25 yoy
-$11.86M
FY 2016derivedN/M FY16 yoy
-$0.05
Q3 2026N/M FY25 yoy
$134.71M
Q3 2026+417.0% FY25 yoy
$1.64B
—
—
12.4×
—
—

FY2025 figures · derived

Price

$8.03+433.22%+$6.52past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2023
$9.32M0FY 2011FY 2012FY 2013FY 2014FY 2019FY 2020FY 2021FY 2022FY 2023
PeriodEndedValueKindSource trail
FY 20232023-12-31$0reported
FY 20222022-12-31$1,000,000reported
FY 20212021-12-31$7,600,000reported
FY 20202020-12-31$1,900,000reported
FY 20192019-12-31$0reported
FY 20142014-12-31$9,319,000reported
FY 20132013-12-31$2,487,000reported
FY 20122012-12-31$0reported
FY 20112011-12-31$0reported

Capital returns

Dividends and buybacks · FY2017 to FY2019
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2019$0.00—$0.00—6.72M sh−71.0%—
FY2018$487.00K—$487.00K—23.18M sh+252.6%—
FY2017$0.00—$0.00—6.57M sh−83.1%—
FY2010—$3.85M$3.85M—18.37M sh——

Pharmaceutical preparations

SELLAS Life Sciences Group, Inc. is the 109th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR